Fundamental Analysis
57 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -77.1% | +99.2% | 2 / 3 | +93.5% | -3.14 pp | -2.37 pp | +21.3% | 1.24 | 2.26 | 2.283 | +93,5% | 7,3 | −77,1% | 2.26 | 4.66 | −51,6% |
| Pts | 0 | 12 | 8 | 12 | 0 | 0 | 12 | 6 | 12 | |||||||
Valuation annotation:Price: 7.100 (close price on 2026-10-19)EPS (TTM): 3.148
Financial charts
1.Revenue & growth
VND bn2.283Q2/26
1.Revenue & growth
VND bn2.283Q2/26
2.Profit & growth
VND bn7,28Q2/26
3.Profit mix (Penman)
VND bn92,4Q2/26
4.Margins & cost structure
%3.9%Q2/26
5.Returns & cash cycle
% · days11.1%Q2/26
6.Earnings quality & cash
VND bn178Q2/26
7.Asset structure
VND bn2.641Q2/26
8.Funding & debt health
VND bn · times2.641Q2/26
9.Revenue backlog
VND bn0,07Q2/26
10.Valuation
times · %2,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %296Q2/26
Adjusted EPS growth, latest quarter
-77.1%
Average adjusted EPS growth, 3 quarters
-77.1%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26